What was the market valuation of the GCC endoscopic retrograde-cholangiopancreatography market in 2024?

The market valuation was $57.1 Million in 2024. Read More

What is the projected market valuation for the GCC endoscopic retrograde-cholangiopancreatography market by 2035?

The projected valuation for 2035 is $159.71 Million. Read More

Which companies are considered key players in the GCC endoscopic retrograde-cholangiopancreatography market?

Key players include Boston Scientific, Medtronic, Olympus Corporation, Cook Medical, Fujifilm Holdings Corporation, Conmed Corporation, Hoya Corporation, and B. Braun Melsungen AG. Read More

What are the revenue figures for the Biliary Stenting procedure segment in the GCC market?

The Biliary Stenting segment generated revenues between $15.0 Million and $40.0 Million. Read More

How do hospitals and clinics compare to ambulatory surgical centers in terms of market share?

Hospitals and clinics accounted for $34.5 Million to $95.5 Million, while ambulatory surgical centers generated $22.6 Million to $64.21 Million. Read More

What is the revenue range for the Bile Duct application segment in the market?

The Bile Duct application segment reported revenues between $22.84 Million and $62.14 Million. Read More

What are the revenue figures for endotherapy devices in the GCC endoscopic retrograde-cholangiopancreatography market?

Endotherapy devices generated revenues ranging from $8.0 Million to $21.0 Million. Read More

What is the revenue range for the Others category in the Biliary Dilatation procedure segment?

The Others category in the Biliary Dilatation segment reported revenues between $12.1 Million and $42.71 Million. Read More

What is the significance of the projected growth in the GCC endoscopic retrograde-cholangiopancreatography market?

The projected growth indicates a robust expansion, with the market expected to reach $159.71 Million by 2035. Read More

GCC Endoscopic Retrograde Cholangiopancreatography Market

Q: What is the expected CAGR for the GCC endoscopic retrograde-cholangiopancreatography market during the forecast period 2025 - 2035?

The expected CAGR during this period is 9.8%. Read More

ID: MRFR/HC/50304-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

GCC Endoscopic Retrograde Cholangiopancreatography Market Research Report By Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Others), By End-user (Hospitals & Clinics, Ambulatory Surgical Centers), By Application (Bile Duct, Pancreas, Others), and By Product (Endoscopes, Imaging Devices, Energy Devices) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Procedure (USD Million)
  1. 4.1.1 Biliary Sphincterotomy
  2. 4.1.2 Biliary Stenting
  3. 4.1.3 Biliary Dilatation
  4. 4.1.4 Pancreatic Duct Stenting
  5. 4.1.5 Others
2. 4.2 Healthcare, BY End User (USD Million)
  1. 4.2.1 Hospitals & Clinics
  2. 4.2.2 Ambulatory Surgical Centers
3. 4.3 Healthcare, BY Application (USD Million)
  1. 4.3.1 Bile Duct
  2. 4.3.2 Pancreas
  3. 4.3.3 Others
4. 4.4 Healthcare, BY Product (USD Million)
  1. 4.4.1 Endoscopes
  2. 4.4.2 Endotherapy Devices
  3. 4.4.3 Catheters
  4. 4.4.4 Stents
  5. 4.4.5 Balloons
  6. 4.4.6 Guiding Wires
  7. 4.4.7 Others
  8. 4.4.8 Imaging Devices
  9. 4.4.9 Energy Devices
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Boston Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Medtronic (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Olympus Corporation (JP)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Cook Medical (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Fujifilm Holdings Corporation (JP)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Conmed Corporation (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hoya Corporation (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 B. Braun Melsungen AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY PROCEDURE
3. 6.3 GCC MARKET ANALYSIS BY END USER
4. 6.4 GCC MARKET ANALYSIS BY APPLICATION
5. 6.5 GCC MARKET ANALYSIS BY PRODUCT
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY PROCEDURE, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY PROCEDURE, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY END USER, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PROCEDURE, 2025-2035 (USD Million)
  2. 7.2.2 BY END USER, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY PRODUCT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC GCC Endoscopic Retrograde Cholangiopancreatography Market Segmentation

GCC Endoscopic Retrograde Cholangiopancreatography Market By Procedure (USD Million, 2025-2035)

Biliary Sphincterotomy
Biliary Stenting
Biliary Dilatation
Pancreatic Duct Stenting
Others

GCC Endoscopic Retrograde Cholangiopancreatography Market By End User (USD Million, 2025-2035)

Hospitals & Clinics
Ambulatory Surgical Centers

GCC Endoscopic Retrograde Cholangiopancreatography Market By Application (USD Million, 2025-2035)

Bile Duct
Pancreas
Others

GCC Endoscopic Retrograde Cholangiopancreatography Market By Product (USD Million, 2025-2035)

Endoscopes
Endotherapy Devices
Catheters
Stents
Balloons
Guiding Wires
Others
Imaging Devices
Energy Devices

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035